GB1459264A - Method of stabilizing a topical ophthalmic formulation - Google Patents

Method of stabilizing a topical ophthalmic formulation

Info

Publication number
GB1459264A
GB1459264A GB1088674A GB1088674A GB1459264A GB 1459264 A GB1459264 A GB 1459264A GB 1088674 A GB1088674 A GB 1088674A GB 1088674 A GB1088674 A GB 1088674A GB 1459264 A GB1459264 A GB 1459264A
Authority
GB
United Kingdom
Prior art keywords
compositions
topical ophthalmic
stabilizing
march
ophthalmic formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1088674A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00341732A external-priority patent/US3824313A/en
Application filed by Allergan Pharmaceuticals Inc filed Critical Allergan Pharmaceuticals Inc
Publication of GB1459264A publication Critical patent/GB1459264A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
GB1088674A 1973-03-16 1974-03-12 Method of stabilizing a topical ophthalmic formulation Expired GB1459264A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00341732A US3824313A (en) 1973-03-16 1973-03-16 Topical opthalmic composition and methods of use
US44568574A 1974-02-25 1974-02-25

Publications (1)

Publication Number Publication Date
GB1459264A true GB1459264A (en) 1976-12-22

Family

ID=26992634

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1088674A Expired GB1459264A (en) 1973-03-16 1974-03-12 Method of stabilizing a topical ophthalmic formulation

Country Status (7)

Country Link
JP (1) JPS5833202B2 (fr)
CA (1) CA1024070A (fr)
DE (1) DE2411019C2 (fr)
DK (1) DK136884B (fr)
ES (1) ES424362A1 (fr)
FR (1) FR2221140B1 (fr)
GB (1) GB1459264A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309209B2 (en) 2010-09-30 2016-04-12 Solvay Sa Derivative of epichlorohydrin of natural origin
WO2020072971A1 (fr) * 2018-10-06 2020-04-09 Biotheravision Llc Préparations ophtalmiques d'agoniste muscarinique et procédés d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300422B (fr) * 1964-07-03 1968-04-29 Astra Ab

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309209B2 (en) 2010-09-30 2016-04-12 Solvay Sa Derivative of epichlorohydrin of natural origin
WO2020072971A1 (fr) * 2018-10-06 2020-04-09 Biotheravision Llc Préparations ophtalmiques d'agoniste muscarinique et procédés d'utilisation

Also Published As

Publication number Publication date
FR2221140B1 (fr) 1977-07-01
ES424362A1 (es) 1976-10-16
AU6679074A (en) 1975-09-18
JPS5833202B2 (ja) 1983-07-18
CA1024070A (fr) 1978-01-10
DE2411019C2 (de) 1986-11-20
JPS5035320A (fr) 1975-04-04
DE2411019A1 (de) 1974-09-26
FR2221140A1 (fr) 1974-10-11
DK136884B (da) 1977-12-12

Similar Documents

Publication Publication Date Title
GB1535770A (en) Pharmaceutical compositions
GB1528723A (en) 1-nitro-9-n-substituted aminoalkylamino-acridines their salts and a method of preparing same
GB1335783A (en) Anti-seborrhoeic compositions
GB1456627A (en) Pyridobenzodiazepinones
GB1142066A (en) New diphenyl-ureas and process for preparing them
GB1174051A (en) Aminophenol Derivatives and Analgesic and Antipyretic Compositions
GB1459264A (en) Method of stabilizing a topical ophthalmic formulation
GB1501958A (en) Alpha-(ureido-or thioureido-)benzyl or cyclohexadienyl methyl penicillins and processes for their preparation
GB1256723A (fr)
GB1252286A (fr)
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1513916A (en) Stable ophthalmic formulation
GB1250353A (fr)
GB1398687A (en) Substituted oxazolidinones and pharmaceutical uses thereof
GB1338124A (en) Phenothiazine derivatives
GB1437788A (en) Therapeutic compositions
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
GB1418595A (en) N- 2-alkoxybenzoyl- amino acids and a process for producing the same
GB1190680A (en) Halocinnamoyl Piperidines and Morpholines and Pharmaceutical Compositions Containing Them
IE37288L (en) Crane assembly
GB1390091A (en) 4-4-biphenylyl-butyric acid derivatives
GB1339010A (en) Tetrazolyl-anthraquinone derivatives
GB1168302A (en) Aluminium N-Acetylglycinate and Pharmaceutical Compositions containing the same
GB1509409A (en) Pharmaceutically active thiozolidine derivatives
GB1457950A (en) Antibacterial compositions

Legal Events

Date Code Title Description
PS Patent sealed
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee